Evidence map›Paper›PMID 33539786›Full record

ArticleMolecular cell2021

Enhancers predominantly regulate gene expression during differentiation via transcription initiation.

Martin S C Larke, Ron Schwessinger, Takayuki Nojima, Jelena Telenius, Robert A Beagrie, Damien J Downes, A Marieke Oudelaar, Julia Truch, Bryony Graham, M A Bender and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. DecipheringBioinformatics advances · 2026
    Article
  5. Article
  6. Article
  7. Is Enhancer Function Driven by Protein-Protein Interactions? From Bacteria to Leukemia.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  8. Article
  9. Loss-of-Function Variants inInternational journal of molecular sciences · 2024
    Review
  10. Molecular models of bidirectional promoter regulation.Current opinion in structural biology · 2024
    Review
  11. Article
  12. Article
  13. A novelFrontiers in genetics · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Intronic enhancers of the humanScience advances · 2022
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Martin S C LarkeMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Ron SchwessingerMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Takayuki NojimaSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Jelena TeleniusMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Robert A BeagrieLaboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Damien J DownesMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
A Marieke OudelaarMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Julia TruchMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Bryony GrahamMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
M A BenderFred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Nicholas J ProudfootSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Douglas R HiggsLaboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Electronic address: doug.higgs@imm.ox.ac.uk.
Jim R HughesMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; MRC WIMM Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Electronic address: jim.hughes@imm.ox.ac.uk.
University of Oxford · GBFred Hutch Cancer Center · US

Funding

FUNCTION OF HUMAN &MOUSE B GLOBIN LOCUS CONTROL REGIONSR37DK044746 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GROUDINE, MARK T · 1997 to 2016
$12.3M
European Research Council 339270Medical Research Council G1000801Medical Research Council MC_PC_15069Medical Research Council MC_U137961144Medical Research Council MC_U137961145Medical Research Council MC_UU_00016/1Medical Research Council MC_UU_00016/12Medical Research Council MC_UU_00016/14Medical Research Council MC_UU_00016/4Medical Research Council MC_UU_12009/13Medical Research Council MC_UU_12009/15Medical Research Council MC_UU_12009/4Medical Research Council MR/T014067/1NIDDK NIH HHS R37 DK044746Wellcome Trust 106130Wellcome Trust 106130/Z/14/ZWellcome Trust 107928Wellcome Trust 107928/Z/15/ZWellcome Trust 209181Wellcome Trust 209181/Z/17/Z
6 · The paper itself

Abstract

Gene transcription occurs via a cycle of linked events, including initiation, promoter-proximal pausing, and elongation of RNA polymerase II (Pol II). A key question is how transcriptional enhancers influence these events to control gene expression. Here, we present an approach that evaluates the level and change in promoter-proximal transcription (initiation and pausing) in the context of differential gene expression, genome-wide. This combinatorial approach shows that in primary cells, control of gene expression during differentiation is achieved predominantly via changes in transcription initiation rather than via release of Pol II pausing. Using genetically engineered mouse models, deleted for functionally validated enhancers of the α- and β-globin loci, we confirm that these elements regulate Pol II recruitment and/or initiation to modulate gene expression. Together, our data show that gene expression during differentiation is regulated predominantly at the level of initiation and that enhancers are key effectors of this process.

Indexed as

Enhancer Elements, GeneticPromoter Regions, GeneticTranscription Initiation, Geneticalpha-GlobinsAnimalsbeta-GlobinsCell DifferentiationExonsFetusGene Expression RegulationGene LibraryHSP70 Heat-Shock ProteinsHumansIntronsK562 CellsLiveralpha-Globinsbeta-GlobinsHSP70 Heat-Shock ProteinsHSPA1A protein, humanMYC protein, humanProto-Oncogene Proteins c-mycRNA Polymerase IIenhancersgene regulationPoll II recruitmentpromoter proximal pausingtranscription

Identifiers

PMID33539786
PMCPMC7612206
OpenAlexW3126260145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.